APIXABAN FDF

Product Description
Medichem S.A.

-
ES
-
2015On CPHI since
-
250 - 499Employees
Company types
Categories
Specifications
Medichem S.A.

-
ES
-
2015On CPHI since
-
250 - 499Employees
Company types
More Products from Medichem S.A. (58)
-
Product Lofexadine
FDF Available for US market -
Product SUGAMMADEX SODIUM FDF
SOLUTION FOR INJECTION ANESTHESIA FDF -
Product PRUCALOPRIDE succinate FDF
film-coated tablets - chronic constipation FDF -
Product DAPTOMYCIN FDF
Medichem S.A. offers wide range of finished dosage forms for licencing which includes Daptomycin. Indication: Antibiotic. Pharmaceutical form: Powder for solution for injection or infusion in glass vial. Strength: 350 mg, 500 mg. Dossier status: EU filed. -
Product RIVAROXABAN FDF
Medichem S.A. offers wide range of pharmaceutical APIs and FDF which includes Rivaroxaban. Indication: Antithrombotic. Contact us for more information. -
Product SUNITINIB MALATE FDF
Medichem S.A. offers a wide range of finished dosage forms for licencing which includes Sunitinib Malate. Indication: Kidney Cancer/ GIT Stromal Tumors. Pharmaceutical form: Capsules. Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg. Dossier status: EU filed. -
Product TOBRAMYCIN FDF
Medichem S.A. offers a wide range of finished dosage forms for licencing which includes Tobramycin. Indication: Cystic Fibrosis. Pharmaceutical form: Solution for inhalation in plastic ampoule blow-fill-seal. Strength: 300 mg/5 ml. Dossier status: EU/BR approved, AU filed, US under prepar... -
Product THALIDOMIDE FDF
capsules 50mg -
Product CAPTOPRIL FDF
Medichem S.A. offers a wide range of finished dosage forms for licencing which includes CAPTOPRIL. Indication: Hypertension Pharmaceutical form: Tablets. Strength: 12.5, 25, 50 and 100 mg. Dossier status: Filed ANDA -
Product SODIUM OXYBATE FDF
Medichem S.A. offers a wide range of finished dosage forms for licencing which includes Sodium Oxybate. Indication: Narcolepsy. Pharmaceutical form: Oral Solution in bottle. Strength: 300 mg/ml. Dossier status: EU approved. -
Product Edavarone FDF
amyotrophic lateral sclerosis (ALS) -
Product LIFITEGRAST FDF
Medichem S.A. offers wide range of pharmaceutical finished dosage forms for licencing which son includes LIFITEGRAST. Indication: Ophtalmic solution. Pharmaceutical form: 5% .
Medichem S.A. resources (2)
-
News API supply chain needs to address future challenges arising from China situation: CPHI Worldwide panel
COVID-19 pandemic has exposed weaknesses and sector faces new challenges driven by rising costs of production in China
Frequently Viewed Together
Recently Visited
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance